Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 243

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 243
---
 a price of approximately $11.98 per share. This resulted in a total redemption payment of $60,856,059, leaving a net trust account balance of approximately $6,233,015 and 520,056 Public Shares outstanding post -redemption. This event significantly reduces the Trust Account balance and the number of Public Shares outstanding, which affects the pro forma calculations and dilution metrics. Accordingly, although these redemptions occurred after the reporting period at the price per share described above, their effects have been reflected in the pro forma Statement of Financial Position using the fair value as of June 30, 2024, which was $11.60 per share (fair value applied in the valuation of the liability for “Common stock subject to possible redemption” in APx financial statements as of said date). The subsequent redemptions impacted the pro forma Statement of Financial Position as follows: (a)Decrease in the Investment held in Trust Account of $58,670,685. (b)Decrease in the Accrued interests receivable of $248,998. (c)Decrease in the liability for Common stock subject to possible redemption of $58,919,683 (5,077,568shares considered at fair value of $11.60).

107

(2)To reflect the release of cash from marketable securities held in the Trust Account together with the Accrued interest receivable in each redemption scenario. For scenario1, which assumes no redemption of Public Shares, no release of cash is reflected. For scenario 2 the 50% redemption of Public Shares, reflects the corresponding release of cash. For scenario 3 the 100% redemption of Public Shares, reflects corresponding release of cash for the entire amount held within the Trust Account. It also includes additional Company Shares issued to Theo I SCSp pursuant to the Backstop Agreement and assumes the obligations under the Backstop Agreement are satisfied through a cash contribution to OmnigenicsAI up to $10,000,000 in an amount that exceeds the aggregate amount of cash on deposit in the Trust Account (including any interest earned on the funds held in the Trust Account) remaining after payment in full of the SPAC Shareholder Redemption Amount, relative to each respective scenario, considering a price of $10 per share. See “ Certain Agreements Related to the Business Combination — Backstop Agreement.” Contributions performed under the Backstop Agreement were calculated as disclosed below: (a)Scenario 1: Considering that the balance in the Trust Account, including accrued interest rece